Join

Store

Chapters

APIC Action Center

Our Action Center makes it easy to action send a relevant letter to your legislators in seconds.

Take Action Now
Menu

Policy Updates

Check insights and updates from APIC!

First Case of Clade I Mpox in US
01/07/2025
First Case of Clade I Mpox in US

The first case of clade I mpox in the U.S. was confirmed by the California Department of Public Health. The patient had recently traveled from a region in Africa where the strain is circulating. The person isolated at home and there is no evidence that mpox clade I is spreading in the U.S.  Read more.

Read More
Baxter Recalls Solution Sets with Duo-Vent Spikes
01/07/2025
Baxter Recalls Solution Sets with Duo-Vent Spikes

The FDA announced that Baxter Healthcare Corporation issued an Urgent Medical Device Recall of certain lots of Solution Sets with Duo-Vent Spikes due to incorrect assembly with inverted side clamps. An inverted side clamp may not allow medication to be delivered, and the patient’s blood may backflow into the set and source container. Read more.

Read More
ASPR Publishes HHS All-Hazards Plan
12/16/2024
ASPR Publishes HHS All-Hazards Plan

The Administration for Strategic Preparedness and Response (ASPR) released the U.S. DHHS All-Hazards Plan, HHS’s emergency operations framework for coordinated departmental response and recovery from disasters and public health emergencies. It provides an all-discipline all-hazards approach to coordinated federal public health, medical, human services, and social services assistance to support state and local governments’ activities … Continued

Read More
APIC Provides Comments on 2025 Leapfrog Hospital Survey
12/12/2024
APIC Provides Comments on 2025 Leapfrog Hospital Survey

APIC provided comments to Leapfrog in response to its proposed updates to the 2025 Leapfrog Hospital Survey. APIC’s recommendations included adding subsections on infection preventionist staffing (Section 5) and patient bathing (Section 6) and reducing the number of required hand hygiene observations (Section 6C). Read APIC’s comments.

Read More
Reminder:  CDC Webinars on NHSN Rebaseline December 18 and 19
12/10/2024
Reminder:  CDC Webinars on NHSN Rebaseline December 18 and 19

The NHSN team has scheduled training webinars on the new 2022 Rebaseline reports. Register here for the Wednesday, December 18 1-2 pm ET webinar on SSI reports. Register here for the Thursday, December 19 2-3 pm ET webinar on MRSA LabID events. Webinars will also be recorded and posted to the NHSN Rebaseline Education webpage.

Read More
CMS Updates Guidance on Defining Immediate Jeopardy for Healthcare Facilities
12/10/2024
CMS Updates Guidance on Defining Immediate Jeopardy for Healthcare Facilities

CMS has issued revised guidance on Appendix Q which indicates when an immediate jeopardy citation is warranted. The full outline and memo can be found here.

Read More
HICPAC November 2024 Meeting Update
12/10/2024
HICPAC November 2024 Meeting Update

CDC’s Healthcare Infection Control Practices Advisory Committee (HICPAC) met November 14-15, 2024 to discuss updates to the Infection Control in Healthcare Personnel Guideline and the Part 1 Draft update to the Isolation Precautions Guideline. The committee approved draft recommendations to the Viral Respiratory Infections section of the IC in HCP Guideline, which will now go … Continued

Read More
NHSN Questionnaire on Supply Disruption of Blood Culture Media Bottles Available December 14
12/10/2024
NHSN Questionnaire on Supply Disruption of Blood Culture Media Bottles Available December 14

The CDC is asking NHSN users to reply to a questionnaire to assess the potential impact on hospitals due to the disruption to the supply of BD BACTECTM blood culture media bottles between June and October 2024. The questionnaire will be available from December 14 – 31, 2024 in the December NHSN newsletter.

Read More
FDA Issues Transitional EtO Enforcement Policy
12/10/2024
FDA Issues Transitional EtO Enforcement Policy

The FDA issued “Transitional Enforcement Policy for Ethylene Oxide (EtO) Sterilization Facility Changes for Class III Devices” to respond to anticipated changes in EtO sterilization activities as facilities work to advance orderly implementation of and compliance with EPA’s 2024 rule which revised emissions standards for EtO. This guidance is intended to prevent or mitigate the … Continued

Read More